Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FHNV5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued on January 23, 2026, with an ultimate completion date of February 13, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion, multi-year contract designated SPE2DR that was awarded on November 13, 2025, and extends through December 31, 2036.
The PPV-G GEN V program represents the Department of Defense's comprehensive pharmaceutical supply strategy, structured to ensure military healthcare facilities worldwide have access to a broad range of branded and generic prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products, including specialty biologics and immunosuppressants such as Stelara, demonstrates its capability to support recurring medical supply requirements across the military healthcare system. No subcontractors are identified in this award documentation.
Quick answers
Who was awarded contract SPE2DR26FHNV5?
SPE2DR26FHNV5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FHNV5 worth?
The government has obligated $16,584 on SPE2DR26FHNV5.
Is contract SPE2DR26FHNV5 an order under another contract?
Yes. SPE2DR26FHNV5 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNV5 competed?
The extent of competition for SPE2DR26FHNV5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award